Skip to main content

Share repurchase programme

In September 2023, we completed a £742m share repurchase programme of our ordinary shares.

Smiths Group plc announced its intention to commence a share repurchase programme of its ordinary shares up to a maximum consideration of £742 million on 11 November 2021. The purpose of the programme was to reduce the share capital of Smiths Group resulting in 55% of the initial cash proceeds from the sale of Smiths Medical being returned to shareholders.

Shareholder approval for the sale of Smiths Medical and the authority to make market purchases of ordinary shares was granted at Smiths Group’s General Meeting held on 17 November 2021.

The programme was completed in five tranches, with the final purchase taking place on 27 September 2023. Details of each tranche can be found below.

Tranche 1 – 19 November 2021 to 17 February 2022 Call to action arrow icon

Tranche 2 - 18 February 2022 to 4 April 2022 Call to action arrow icon

Tranche 3 - 8 April 2022 to 5 July 2022 Call to action arrow icon

Tranche 4 – 6 July 2022 to 15 October 2022 Call to action arrow icon

Tranche 5 – 17 October 2022 to 27 September 2023 Call to action arrow icon

Sale of Smiths Medical

Smiths sold Smiths Medical on 2 January 2022

Sale of Smiths Medical - Slide Deck

Sale of Smiths Medical - Shareholder Circular